Login / Signup

Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma.

Yongchao LiangYing ZhuYing ZhangZiwei ChenBoyang LiAijun LiuLi-Hong Liu
Published in: Journal of healthcare engineering (2022)
There was no difference between the two groups of effectiveness or safety, and the generic drug is more economical in the treatment.
Keyphrases
  • multiple myeloma
  • randomized controlled trial
  • emergency department
  • adverse drug